Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu

Journal of Nervous and Mental Disease

Volumn 155, Issue 4, 1972, Pages 245-256

  Singh, Man Mohan ^a   Discipio, William J ^a  

^a Departments of Pathology and Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BENZATROPINE; HALOPERIDOL;

ANXIETY; ARTICLE; ATTITUDE; CLINICAL TRIAL; HUMAN; IATROGENIC DISEASE; MILIEU THERAPY; MOTOR DYSFUNCTION; NEUROSIS; PERSONALITY TEST; SCHIZOPHRENIA;

ANTIPARKINSON AGENTS; ANXIETY; ATTITUDE OF HEALTH PERSONNEL; BENZTROPINE; CLINICAL TRIALS; EVALUATION STUDIES; HALOPERIDOL; HUMAN; MILIEU THERAPY; MOVEMENT DISORDERS; NEUROTIC DISORDERS; PERSONALITY INVENTORY; SCHIZOPHRENIA;

EID: 0015416753     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/00005053-197210000-00003     Document Type: Article

References (19)

1. Cooper, B. Group therapy and tranquilizers in the chronic ward. Br. J. Psychiatry, 34: 157-162, 1961.
2. Cumming, J. and Cumming, E. Ego and Milieu. Atherton, New York, 1962.
3. Evangelakis, M. G. De-institutionalization of patients. Dis. Nerv. Syst., 22: 26-32,1961.
4. Eysenck, H. J. and Eysenck, S. B. G. Manual of the Eysenck Personality Inventory. University of London Press, London, 1964.
5. Giurgea, C. In Bobon, D. P., Janssen, P. A., and Bobon, J., eds. The Neuroleptics, pp. 93-94. Karger, New York, 1970.
6. Gorham, D. R. and Pokorny, A. D. Effects of phenothiazine and/or group psychotherapy with schizophrenics. Dis. Nerv. Syst., 25: 77-86, 1964.
7. Greenblatt, M., Solomon, M. H., Evan, A. S. and Brooks, G. W., eds. Drug and Social Therapy in Chronic Schizophrenia. Charles C Thomas, Springfield, Ill., 1965.
8. Herz, M. I. The therapeutic community: A critique. Hosp. Community Psychiatry, 23(3): 17-20,1972.
9. Honigfeld, G. Non-specific factors in treatment. II. Review of social-psychological factors. Dis. Nerv. Syst., 25: 225-239,1964.
10. Knobel, M. The environmental ‘antidrug effect.’ Psychiatry, 23: 403-407,1960.
11. May, P. R. A. ‘ Treatment of Schizophrenia. Science House, New York, 1968.
12. Moos, R. H. Differential effects of ward settings on psychiatric patients. A replication and extension. J. Nerv. Ment. Dis., 147: 386-393, 1968.
13. Moos, R. H. and Daniels, D. N. Differential effects of ward settings on psychiatric staff. Arch. Gen. Psychiatry, 17: 75-82, 1967.
14. Rickels, K. (ed.) Non-Specific Factors in Drug Therapy. Charles C Thomas, Springfield, Ill., 1968.
15. Sabshin, M. and Eisen, S. B. The effects of ward tension on the quality and quantity of tranquilizer utilization. Ann. N.Y. Acad. Sci., 67: 746-757,1957.
16. Sherman, L. J. The significant variables in psy-chopharmaceutic research. Am. J. Psychiatry, 116: 208-214, 1959.
17. Singh, M. M. Psychopharmacological study of schizophrenia-new strategies. A case study with haloperidol. Paper presented at V World Congress of Psychiatry, Mexico City, 1971.
18. Singh, M. M. and Smith, J. M. Reversal of some therapeutic effects of haloperidol (Haldol®) by anti-Parkinson drugs. Paper Presented at the Joint Meeting of Amer. Soc. Pharm. Exp. Ther. and Div. Med. Chem. Amer. Chem. Soc., Burlington, Vt., 1971.
19. Stanton, A. H. and Schwartz, M. S. The Mental Hospital. Basic Books, New York, 1954.